MEENAKSHI ANURAG to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications MEENAKSHI ANURAG has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.236
-
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022 11 02; 12(11):2586-2605.
Score: 0.116
-
CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree? Clin Cancer Res. 2020 01 01; 26(1):3-5.
Score: 0.094
-
Immunogenomic?profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer. Breast Cancer Res Treat. 2021 Aug; 189(1):187-202.
Score: 0.026